Opiant Pharmaceuticals Inc

NASDAQ:OPNT   1:00:00 PM EDT
20.08
0.00 (0.00%)
3:13:07 PM EDT: $20.06 -0.02 (-0.10%)
Mergers / Acquisitions

Indivior To Acquire Opiant Pharmaceuticals

Published: 11/14/2022 07:21 GMT
Opiant Pharmaceuticals Inc (OPNT) - Indivior to Acquire Opiant Pharmaceuticals.
Opiant- Indivior Will Acquire Outstanding Shares of Opiant for Upfront Consideration of $20.00 per Share in Cash, Plus Up to $8.00 per Share in Cvrs.
Indivior Expects to Fund Aggregate Upfront Consideration of Approximately $145 Million With Existing Cash.
Parties Anticipate Completing Transaction in Q1 of 2023.
Opiant Pharmaceuticals - Acquisition Expected to Be Accretive to Earnings After the Second Full Year of Launch of Opnt003.